|
Market Closed -
Nasdaq
16:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 13.28 USD | -2.35% |
|
-1.63% | +135.04% |
| 08-14 | BofA Adjusts Price Target on Candel Therapeutics to $12 From $9 | MT |
| 08-13 | Candel Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.35% | -1.63% | +38.91% | +67.04% | +135.04% | +122.82% | +925.48% | +69.39% | - | 1.02B | |
| -0.20% | +0.31% | +5.04% | +18.28% | +9.26% | +2.66% | +23.58% | -24.45% | +214.90% | 50.96B | |
| +1.92% | +0.36% | +13.85% | +39.09% | +170.48% | +477.97% | +550.09% | +685.70% | - | 46.18B | |
| -0.15% | -0.28% | +15.31% | +24.26% | +23.70% | +21.65% | +89.41% | +32.88% | +1,242.62% | 42.73B | |
| +0.81% | +4.91% | +25.70% | +61.43% | +16.02% | +39.28% | +19.41% | +1.17% | +245.50% | 43.04B | |
| -2.27% | -3.02% | +6.76% | +0.19% | +9.99% | +14.22% | +51.50% | -18.22% | +145.06% | 33.48B | |
| +0.81% | +1.77% | +2.94% | +44.26% | +10.22% | +31.91% | +138.26% | +244.51% | +2,181.79% | 17.28B | |
| -1.08% | -3.61% | -1.42% | +4.42% | - | - | - | - | - | 16.43B | |
| -0.49% | -0.49% | +8.28% | +16.01% | +16.12% | +11.20% | +27.93% | -39.04% | +97.36% | 14.73B | |
| -0.85% | +1.76% | +30.24% | +88.29% | +47.93% | +80.26% | +47.26% | -32.57% | +255.07% | 14.09B | |
| +0.01% | -2.06% | +1.91% | +48.38% | -7.29% | -1.65% | -34.09% | -33.23% | +124.37% | 13.03B | |
| -0.36% | +11.80% | +60.41% | +46.76% | +15.97% | -10.25% | - | - | - | 12.36B | |
| +3.48% | -9.25% | +20.48% | +79.99% | +63.28% | +45.88% | +63.80% | -46.57% | - | 11.12B | |
| +0.07% | -0.14% | +1.09% | +50.89% | +23.07% | +27.45% | -9.71% | -41.30% | +173.96% | 11.35B | |
| +0.60% | +0.80% | -10.78% | -10.14% | -16.11% | +46.80% | +469.98% | +245.89% | +2,369.44% | 10.94B | |
| -0.33% | +4.21% | +12.04% | -16.71% | -19.91% | +50.25% | +57.14% | +62.88% | +105.05% | 10.53B | |
| -0.86% | -1.38% | +13.55% | +55.44% | +61.35% | +186.19% | +539.26% | +114.43% | - | 10.44B | |
| +2.54% | -2.28% | +16.01% | +7.64% | +28.03% | +687.83% | +1,577.20% | +38.84% | - | 10.54B | |
| +0.07% | +0.18% | +0.50% | +62.96% | +78.79% | +256.35% | +468.21% | - | - | 10.18B | |
| +0.40% | +6.41% | +111.06% | +134.17% | +185.83% | +104.73% | +90.86% | -4.31% | +1,640.20% | 9.86B | |
| Average | -0.03% | +1.70% | +18.59% | +41.13% | +44.83% | +115.56% | +283.09% | +73.88% | +732.94% | 19.51B | |
| Weighted average by Cap. | -0.11% | +1.46% | +15.19% | +35.41% | +42.42% | +111.86% | +196.96% | +108.22% | +621.28% |
- Stock Market
- Stocks
- CADL Stock
- Sector Candel Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
